Cargando…

Generation of gene-corrected functional osteoclasts from osteopetrotic induced pluripotent stem cells

BACKGROUND: Infantile malignant osteopetrosis (IMO) is an autosomal recessive disorder characterized by non-functional osteoclasts and a fatal outcome early in childhood. About 50% of patients have mutations in the TCIRG1 gene. METHODS: IMO iPSCs were generated from a patient carrying a homozygous c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xian, Xiaojie, Moraghebi, Roksana, Löfvall, Henrik, Fasth, Anders, Henriksen, Kim, Richter, Johan, Woods, Niels-Bjarne, Moscatelli, Ilana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227215/ https://www.ncbi.nlm.nih.gov/pubmed/32414402 http://dx.doi.org/10.1186/s13287-020-01701-y

Ejemplares similares

Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts
por: Neri, Tui, et al.
Publicado: (2015)

Retinoic Acid Regulates Hematopoietic Development from Human Pluripotent Stem Cells
por: Rönn, Roger E., et al.
Publicado: (2015)

Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes
por: Löfvall, Henrik, et al.
Publicado: (2018)

Cyclic AMP Signaling through Epac Axis Modulates Human Hemogenic Endothelium and Enhances Hematopoietic Cell Generation
por: Saxena, Shobhit, et al.
Publicado: (2016)

Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor
Publicado: (1991)

Schlafen2 mutation in mice causes an osteopetrotic phenotype due to a decrease in the number of osteoclast progenitors
por: Omar, Ibrahim, et al.
Publicado: (2018)

Delayed hematopoietic development in osteopetrotic (op/op) mice
Publicado: (1993)

Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods
por: Okur, Fatma Visal, et al.
Publicado: (2019)

P03-021 - Characterization of BM-MSC from osteopetrotic mice
por: Schena, F, et al.
Publicado: (2013)

Maternal RANKL Reduces the Osteopetrotic Phenotype of Null Mutant Mouse Pups
por: Navet, Benjamin, et al.
Publicado: (2018)

Further understanding on osteopetrotic femoral fractures: a case report and literature review
por: Ding, Haiqi, et al.
Publicado: (2021)

Alterations in Hematopoietic and Mesenchymal Stromal Cell Components of the Osteopetrotic Bone Marrow Niche
por: Zeytin, Inci Cevher, et al.
Publicado: (2022)

Term amniotic fluid: an unexploited reserve of mesenchymal stromal cells for reprogramming and potential cell therapy applications
por: Moraghebi, Roksana, et al.
Publicado: (2017)

GPDPLQ(1237)—A Type II Collagen Neo-Epitope Biomarker of Osteoclast- and Inflammation-Derived Cartilage Degradation in vitro
por: Löfvall, Henrik, et al.
Publicado: (2019)

Osteopetrotic (op/op) mice have reduced microglia, no Aβ deposition, and no changes in dopaminergic neurons
por: Kondo, Yoichi, et al.
Publicado: (2007)

Combining naproxen and a dual amylin and calcitonin receptor agonist improves pain and structural outcomes in the collagen-induced arthritis rat model
por: Katri, Anna, et al.
Publicado: (2019)

The Alternative Faces of Macrophage Generate Osteoclasts
por: Lampiasi, N., et al.
Publicado: (2016)

Gene therapy for infantile malignant osteopetrosis: review of pre-clinical research and proof-of-concept for phenotypic reversal
por: Moscatelli, Ilana, et al.
Publicado: (2020)

Alterations in osteoclast function and phenotype induced by different inhibitors of bone resorption - implications for osteoclast quality
por: Neutzsky-Wulff, Anita V, et al.
Publicado: (2010)

Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential
por: Kyttälä, Aija, et al.
Publicado: (2016)

Regulation of differentiation and generation of osteoclasts in rheumatoid arthritis
por: Niu, Qing, et al.
Publicado: (2022)

Novel population of human monocyte and osteoclast progenitors from pluripotent stem cells and peripheral blood
por: Root, Sierra H., et al.
Publicado: (2021)

Osteosarcoma and Metastasis Associated Bone Degradation—A Tale of Osteoclast and Malignant Cell Cooperativity
por: Nørregaard, Kirstine Sandal, et al.
Publicado: (2021)

Craniometaphyseal Dysplasia Mutations in ANKH Negatively Affect Human Induced Pluripotent Stem Cell Differentiation into Osteoclasts
por: Chen, I-Ping, et al.
Publicado: (2017)

Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins
por: Blümke, Alexander, et al.
Publicado: (2023)

Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins
por: Blümke, Alexander, et al.
Publicado: (2023)

Origin of Osteoclasts: Osteoclast Precursor Cells
por: Tsai, Jefferson, et al.
Publicado: (2023)

Podosome rings generate forces that drive saltatory osteoclast migration
por: Hu, Shiqiong, et al.
Publicado: (2011)

The effect of surgical suture material on osteoclast generation and implant-loosening
por: Dapunt, Ulrike, et al.
Publicado: (2021)

Osteoclast
Publicado: (1877)

Transcriptome sequencing identifies a noncoding, deep intronic variant in CLCN7 causing autosomal recessive osteopetrosis
por: Chorin, Odelia, et al.
Publicado: (2020)

Retinoic Acid Increases Proliferation of Human Osteoclast Progenitors and Inhibits RANKL-Stimulated Osteoclast Differentiation by Suppressing RANK
por: Hu, Lijuan, et al.
Publicado: (2010)

The estrogen-related receptor γ modulator, GSK5182, inhibits osteoclast differentiation and accelerates osteoclast apoptosis
por: Kim, Hyun-Ju, et al.
Publicado: (2021)

Generation of Human‐Induced Pluripotent Stem Cells From Anterior Cruciate Ligament
por: Woods, Steven, et al.
Publicado: (2019)

Dissociation of Bone Resorption and Bone Formation in Adult Mice with a Non-Functional V-ATPase in Osteoclasts Leads to Increased Bone Strength
por: Henriksen, Kim, et al.
Publicado: (2011)

Oleoylethanolamide Exhibits GPR119-Dependent Inhibition of Osteoclast Function and GPR119-Independent Promotion of Osteoclast Apoptosis
por: Kim, Hyun-Ju, et al.
Publicado: (2020)

Matrix Metalloproteinase 9 and Vascular Endothelial Growth Factor Are Essential for Osteoclast Recruitment into Developing Long Bones
por: Engsig, Michael T., et al.
Publicado: (2000)

Human primary osteoclasts: in vitro generation and applications as pharmacological and clinical assay
por: Susa, Mira, et al.
Publicado: (2004)

Zoledronic Acid Is Not Equally Potent on Osteoclasts Generated From Different Individuals
por: Møller, Anaïs M J, et al.
Publicado: (2020)

Interleukin-32 Promotes Osteoclast Differentiation but Not Osteoclast Activation
por: Mabilleau, Guillaume, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_rb8nn1limcpcdi36t3c643anvf